Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

LumiraDx Instrument for Rapid Detection of SARS-CoV-2

Innovative microfluidic technology delivers exceptional clinical performance in minutes, Used with the LumiraDx SARS-CoV-2 Ag Test

Supplier:  LumiraDx L001000330001

Catalog No. 22-181-000

Due to product restrictions, please to purchase or view availability for this product.

This item is not returnable. View return policy



  • Features:
    • Innovative, next generation point of care system that combines a small, portable instrument, advanced low-cost test strip and seamless digital connectivity
    • Delivers exceptional point of care clinical performance
    • Simple and easy to use
    • Performance referenced to laboratory test
    • Portable instrument, seamless connectivity
    • One simple, intuitive test workflow
    • Fast results in minutes
    • Nasal swab specimen type
    • Room temperature storage
    • Used with the LumiraDx SARS-CoV-2 Ag Test
  • Notes:
    • Orders require executed contractual agreement
      • Please contact your Fisher Healthcare Account Representative for more information
    • This test has not been FDA cleared or approved; but has been authorized by FDA under EUA for use by authorized laboratories; use by laboratories certified under the CLIA, 42 U.S.C. §263a, that meet requirements to perform moderate, high or waived complexity tests
    • Test authorized for use at the Point of Care (POC), i.e., in patient care settings operating under a CLIA Certificate of Waiver, Certificate of Compliance, or Certificate of Accreditation
    • Authorized only for the detection of proteins from SARS-CoV-2, not for any other viruses or pathogens
    • In USA, test is only authorized for duration of declaration that circumstances exist justifying the authorization of emergency use of in vitro diagnostics for detection and/or diagnosis of the virus that causes COVID-19 under Section 564(b)(1) of the Federal Food, Drug, and Cosmetic Act, 21 U.S.C. § 360bbb-3(b)(1), unless authorization is terminated or revoked sooner


Proteins from SARS to CoV to 2
Used with LumiraDx SARS-CoV-2 Ag Test
Portable instrument


Product Certifications


Provide Content Correction

We continue to work to improve your shopping experience and your feedback regarding this content is very important to us. Please use the form below to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Cancel Submit

Authorized under EUA for use by authorized labs, test has not been FDA cleared or approved